Author

Zoe Hareng

Observed names: Z. Hareng, Z.M. Hareng, Zoe M Hareng

Institution: California Baptist University

Observed institutions: Hoag Memorial Hospital Presbyterian, California Baptist University

OpenAlex ID: A5117066796

Ventriculoperitoneal shunt management in patients with normal pressure hydrocephalus and cerebral atrophy

2026 · Karlyssa Chung, Zoe Hareng, et al. · JAAPA · 1

Interim Results of a "First-in-Human" Phase 1 Clinical Study of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous, Wnt-Activated, Adipose-Derived Stem Cells in Participants with Mild to Moderate Alzheimer's Disease

2025 · C.M. Duma, H. Keirstead, et al. · Cytotherapy · 1

First-in-human Phase 1 Study of Intracerebroventricular Injection of Autologous, Wnt-activated, Adipose-derived Stem Cells in Mild to Moderate Alzheimer’s Disease: 1-year Follow-up

2026 · C.M. Duma, J.J. Buxton, et al. · Cytotherapy

Early results of a "First‐in‐Human" Phase 1 clinical study of intracerebroventricular injections of ex vivo expanded, autologous, Wnt‐activated, adipose‐derived stem cells in participants with mild to moderate Alzheimer's Disease (AD)

2025 · Christopher M. Duma, Hans Keirstead, et al. · Alzheimer s & Dementia

Intracerebroventricular Injection of Autologous Adipose-Derived Stem Cells for the Treatment of Alzheimer’s Disease: Experience with the First of Three, 3-patient Cohorts in a “First-in-Human” Phase 1 FDA Trial (P12-3.005)

2025 · Christopher Duma, Hans Keirstead, et al. · Neurology

Works count: 5

Citation count: 2

H-index: 1

I10-index: